tradingkey.logo
tradingkey.logo
Search

STAAR Surgical Co

STAA
Add to Watchlist
22.780USD
-0.400-1.73%
Market hours 08/26, 13:27ET
1.14BMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-1.73%

5 Days

-7.55%

1 Month

-2.57%

6 Months

+13.16%

Year to Date

-1.34%

1 Year

-17.13%

Key Figures
23.105Open
23.060High
11.51KVolume
LossP/E TTM
41.91P/E Dynamic
--Dividend TTM
0.02%Turnover Ratio
23.180Prev. Close
22.600Low
262.00KTurnover
LossP/E Static
3.13P/B
0.00%Div Yield TTM
-4.63%ROA
35.87052wk High
0.03Volume Ratio
-20.21MNet Profit
50.12MShares
-0.4200EPS TTM
1.23Beta
-5.99%ROE
15.59052wk Low
1.98%Amplitude
74.55%Gross Margin
1.14BMarket Cap
2.90Reward/Risk
3.45%Risk Rate

Recent

Analysis

Earnings

Transcripts

More news coming soon, stay tuned...

STAAR Surgical Co's Score

-0.12vs previous score
Forecast6.73
Financial Health8.56
Technical3.50
Valuation Dimensions7.92
Institutional Confidence10.00
Risk Assessment6.71

Media Coverage

Coverage Level

Very Low
Very High
Positive+

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
HoldCurrent Rating
27.900Target Price
+20.57%Upside Space
Current Rating2026-082026-072026-062026-052026-042026-032026-022026-01
Strong Buy11000000
Buy22210000
Hold8891010999
Sell00001100
Strong Sell00000000

STAAR Surgical Co Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D

Technical Indicators

Strong sell

Summary

Sell

Moving Average

Strong sell

STAAR Surgical Co Latest Earnings Call Transcripts

STAAR Surgical (STAA) Q2 2026 Earnings Call: China and EVO Plus Drive 111% Sales Growth

STAAR Surgical Q2 2026 sales rose 111% to $93.5 million as China and EVO Plus drove growth. Net income reached $8.1 million and cash increased to $181.5 million.

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
0.16/0.16
Revenue / Forecast
93.53M/90.59M

STAAR Surgical Co Profile

SectorHealthcare Equipment & Supplies
Ticker SymbolSTAA
Number of employees1157
CountryUnited States of America

Ownership

ShareholdersProportion
Broadwood Capital, Inc.32.38%
BlackRock Institutional Trust Company, N.A.13.44%
Yunqi Capital Limited6.54%
Madison Avenue Partners LP5.73%
Shareholder TypesProportion
Hedge Fund53.68%
Investment Advisor31.49%
Investment Advisor/Hedge Fund21.11%
Research Firm6.23%

FAQs

What is the current price of STAAR Surgical Co (STAA)?

The current price of STAAR Surgical Co (STAA) is 23.18.

What is the symbol of STAAR Surgical Co?

The ticker symbol of STAAR Surgical Co is STAA.

What is the 52-week high of STAAR Surgical Co?

The 52-week high of STAAR Surgical Co is 35.87.

What is the 52-week low of STAAR Surgical Co?

The 52-week low of STAAR Surgical Co is 15.59.

What is the market capitalization of STAAR Surgical Co?

The market capitalization of STAAR Surgical Co is 1.16B.

Is STAAR Surgical Co (STAA) currently rated as Buy, Hold, or Sell?

According to analysts, STAAR Surgical Co (STAA) has an overall rating of signal_hold, with a price target of 27.90.

What is the Earnings Per Share (EPS TTM) of STAAR Surgical Co (STAA)?

The Earnings Per Share (EPS TTM) of STAAR Surgical Co (STAA) is -0.42.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.